Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Labcorp Holdings (LH – Research Report), ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

The overall quality of each Unit of Assessment NTU submitted to REF in 2021 also saw an improvement from the previous REF in 2014. The Rosalind Franklin Building is home to Chemistry at NTU and armed ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PacBio (PACB) announced the appointment of Chris Smith to its Board of Directors, effective today. Smith is currently the Chief Executive Officer of NeoGenomics (NEO). Published first on TheFly ...

PacBio to leverage Chris' extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down. MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio ...

The company is known for pioneering DNA sequencing. Chris Smith, CEO of oncology diagnostic company NeoGenomics Inc., is getting a seat on the board of Pacific Biosciences of California Inc ...

MENLO PARK, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leader in high-quality, long-read sequencing, is proud to announce its critical role in a study to be published in Nature ...